Micardis and Betaxolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micardis (telmisartan) and Betaxolol (betaxolol hydrochloride). Common drug interactions include drug ineffective among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Micardis and Betaxolol. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Betaxolol?

Betaxolol has active ingredients of betaxolol hydrochloride. eHealthMe is studying from 1,680 Betaxolol users. Check the latest studies of Betaxolol.



On Jul, 17, 2026

27 people who take Micardis and Betaxolol together, and have interactions are studied.

Micardis and Betaxolol drug interactions.

What are the common drug interactions of Micardis and Betaxolol, by gender? *:

female:

  1. Drug ineffective
  2. Hypertensive crisis
  3. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  4. Cerebrovascular disorder (disease of brain)
  5. Albuminuria (albumin is present in the urine)
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Hyperglycaemia (high blood sugar)
  9. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  10. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

male:

  1. Renal failure (kidney dysfunction)
  2. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  3. Multi-organ disorder (multiple organ disease)
  4. Oedema (fluid collection in tissue)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Splenic rupture
  9. Abdominal pain
  10. Blood pressure decreased

What are the common drug interactions of Micardis and Betaxolol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug ineffective
  2. Hypertensive crisis
  3. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  4. Cerebrovascular disorder (disease of brain)
  5. Albuminuria (albumin is present in the urine)
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Hyperglycaemia (high blood sugar)
  9. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

60+:

  1. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  2. Splenic rupture
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Drug level increased
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Hypersensitivity
  7. Mixed liver injury
  8. Renal failure (kidney dysfunction)
  9. Abdominal pain
  10. Blood pressure decreased

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 11 people, 40.74%
  2. Diabetes: 9 people, 33.33%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 9 people, 33.33%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 11.11%
  5. Type 2 Diabetes: 2 people, 7.41%
  6. Enlarged Heart: 2 people, 7.41%
  7. Chest Pain: 2 people, 7.41%
  8. Cough: 2 people, 7.41%
  9. Dyslipidaemia (abnormal amount of lipids): 2 people, 7.41%
  10. Heart Attack: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and Betaxolol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micardis and Betaxolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Betaxolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micardis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Betaxolol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and betaxolol hydrochloride (the active ingredients of Micardis and Betaxolol, respectively), and Micardis and Betaxolol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: